Literature DB >> 2362909

Epimerization kinetics of moxalactam in frozen urine and plasma samples.

N Hashimoto1, T Ichihashi, K Hirano, H Yamada.   

Abstract

The epimerization of moxalactam (LMOX) in frozen urine and plasma samples was studied during long-term storage. The R/S ratio at equilibrium [(R/S)eq] at -10 degrees C was similar in urine and in rat and human plasma ultrafiltrate but differed from that in water. The (R/S)eq values in human plasma and its ultrafiltrate differed slightly, while they were the same in rat plasma and in its ultrafiltrate. The difference for the human plasma and ultrafiltrate may result from differences in plasma protein binding between R- and S-epimers in the liquid region of the frozen plasma. The change of R/S ratio in frozen human plasma continued below the collapse temperature of LMOX aqueous solution, where the liquid region appeared still to exist as determined by NMR measurement. Consequently, the biological LMOX samples should be preserved at or below -70 degrees C to prevent changes in the R/S ratio.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2362909     DOI: 10.1023/a:1015815321570

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

1.  Activity, stability, and pharmacology of the epimers of moxalactam.

Authors:  R Wise; N Wright; P J Wills
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

2.  Plasma protein binding and urinary excretion of R- and S-epimers of an arylmalonylamino 1-oxacephem II: In rats.

Authors:  H Yamada; T Ichihashi; K Hirano; H Kinoshita
Journal:  J Pharm Sci       Date:  1981-01       Impact factor: 3.534

3.  Plasma protein binding and urinary excretion of R- and S-epimers of an arylmalonylamino 1-oxacephem. I: In humans.

Authors:  H Yamada; T Ichihashi; K Hirano; H Kinoshita
Journal:  J Pharm Sci       Date:  1981-01       Impact factor: 3.534

4.  Epimerization kinetics of moxalactam in frozen solution.

Authors:  N Hashimoto; T Ichihashi; E Yamamoto; K Hirano; M Inoue; H Tanaka; H Yamada
Journal:  Pharm Res       Date:  1988-05       Impact factor: 4.200

5.  Epimers of moxalactam: in vitro comparison of activity and stability.

Authors:  R Wise; P J Wills; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

6.  High-performance liquid chromatographic analysis of a new beta-lactam antibiotic, 6059-S (moxalactam).

Authors:  R Konaka; K Kuruma; R Nishimura; Y Kimura; T Yoshida
Journal:  J Chromatogr       Date:  1981-09-11
  6 in total
  1 in total

1.  Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children.

Authors:  Yang Wang; Dan Sun; Yan Mei; Sanlan Wu; Xinlin Li; Sichan Li; Jun Wang; Liuliu Gao; Hua Xu; Yali Tuo
Journal:  Pharmaceutics       Date:  2022-05-11       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.